Co-Diagnostics Price to Book Ratio

The latest P/B ratio for CODX is 0.38. That is below the Healthcare sector average of 6.23. Investors often review this figure alongside Co-Diagnostics's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, CODX currently prints 0.38 for P/B ratio, while the sector average sits near 6.23. That is roughly 93.8% below the sector mean. Large gaps often invite a closer look at Co-Diagnostics's growth, margins, and balance sheet.

A P/B ratio of 0.38 for Co-Diagnostics is not 'good' or 'bad' on its own. Compare it with the peer average (6.23) and with CODX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting CODX's P/B ratio (0.38), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Co-Diagnostics's P/B ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.